Literature DB >> 25030653

Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?

R Sapir-Koren1, G Livshits.   

Abstract

Osteocytes, entrapped within a newly mineralized bone matrix, possess a unique cellular identity due to a specialized morphology and a molecular signature. These features endow them to serve as a bone response mechanism for mechanical stress in their microenvironment. Sclerostin, a primarily osteocyte product, is widely considered as a mechanotranduction key molecule whose expression is suppressed by mechanical loading, or it is induced by unloading. This review presents a model suggesting that sclerostin is major mediator for integrating mechanical, local, and hormonal signals, sensed by the osteocytes, in controlling the remodeling apparatus. This central role is achieved through interplay between two opposing mechanisms: (1) unloading-induced high sclerostin levels, which antagonize Wnt-canonical-β-catenin signaling in osteocytes and osteoblasts, permitting simultaneously Wnt-noncanonical and/or other pathways in osteocytes and osteoclasts, directed at bone resorption; (2) mechanical loading results in low sclerostin levels, activation of Wnt-canonical signaling, and bone formation. Therefore, adaptive bone remodeling occurring at a distinct bone compartment is orchestrated by altered sclerostin levels, which regulate the expression of the other osteocyte-specific proteins, such as RANKL, OPG, and proteins encoded by "mineralization-related genes" (DMP1, PHEX, and probably FGF23). For example, under specific terms, sclerostin regulates differential RANKL and OPG production, and creates a dynamic RANKL/OPG ratio, leading either to bone formation or resorption. It also controls the expression of PHEX, DMP1, and most likely FGF23, leading to either bone matrix mineralization or its inhibition. Such opposing up- or down-regulation of remodeling phases allows osteocytes to function as an "external unit", ensuring transition from bone resorption to bone formation.Mini Abstract: The osteocyte network plays a central role in directing bone response either to mechanical loading, or to unloading, leading correspondingly to bone formation or resorption. This review shows a key role of the osteocyte-produced sclerostin as a major mediator of the molecular mechanisms involved in the process of adaptive bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030653     DOI: 10.1007/s00198-014-2808-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  125 in total

1.  The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.

Authors:  Kimihiko Sawakami; Alexander G Robling; Minrong Ai; Nathaniel D Pitner; Dawei Liu; Stuart J Warden; Jiliang Li; Peter Maye; David W Rowe; Randall L Duncan; Matthew L Warman; Charles H Turner
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

2.  Increased intracortical remodeling following fatigue damage.

Authors:  S Mori; D B Burr
Journal:  Bone       Date:  1993 Mar-Apr       Impact factor: 4.398

3.  Local bone formation due to combined mechanical loading and intermittent hPTH-(1-34) treatment and its correlation to mechanical signal distributions.

Authors:  M D Roberts; T J Santner; R T Hart
Journal:  J Biomech       Date:  2009-09-26       Impact factor: 2.712

4.  Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Authors:  Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

5.  Evidence for the role of osteocytes in the initiation of targeted remodeling.

Authors:  Terhi J Heino; Kosaku Kurata; Hidehiko Higaki; H Kalervo Väänänen
Journal:  Technol Health Care       Date:  2009       Impact factor: 1.285

6.  Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.

Authors:  Masakazu Kogawa; Asiri R Wijenayaka; Renee T Ormsby; Gethin P Thomas; Paul H Anderson; Lynda F Bonewald; David M Findlay; Gerald J Atkins
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

7.  Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.

Authors:  Xiaodong Li; Michael S Ominsky; Qing-Tian Niu; Ning Sun; Betsy Daugherty; Diane D'Agostin; Carole Kurahara; Yongming Gao; Jin Cao; Jianhua Gong; Frank Asuncion; Mauricio Barrero; Kelly Warmington; Denise Dwyer; Marina Stolina; Sean Morony; Ildiko Sarosi; Paul J Kostenuik; David L Lacey; W Scott Simonet; Hua Zhu Ke; Chris Paszty
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

Review 8.  Sclerostin: current knowledge and future perspectives.

Authors:  M J C Moester; S E Papapoulos; C W G M Löwik; R L van Bezooijen
Journal:  Calcif Tissue Int       Date:  2010-05-15       Impact factor: 4.333

9.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

10.  Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice.

Authors:  Ina Kramer; Gabriela G Loots; Anne Studer; Hansjoerg Keller; Michaela Kneissel
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

View more
  48 in total

Review 1.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

2.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

3.  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Jannis Kountouras; Polyzois Makras; Athanasios Papatheodorou; Panagiotis Kokkoris; Grigorios T Sakellariou; Evangelos Terpos
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

4.  Analysis of microscopic bone properties in an osteoporotic sheep model: a combined biomechanics, FE and ToF-SIMS study.

Authors:  R Müller; A Henss; M Kampschulte; M Rohnke; A C Langheinrich; C Heiss; J Janek; A Voigt; H J Wilke; A Ignatius; J Herfurth; T El Khassawna; A Deutsch
Journal:  J R Soc Interface       Date:  2019-02-28       Impact factor: 4.118

5.  Utilization of Mechanical Stress to Treat Osteoporosis: The Effects of Electrical Stimulation, Radial Extracorporeal Shock Wave, and Ultrasound on Experimental Osteoporosis in Ovariectomized Rats.

Authors:  Shota Inoue; Junpei Hatakeyama; Hitoshi Aoki; Hiroshi Kuroki; Takahiro Niikura; Keisuke Oe; Tomoaki Fukui; Ryosuke Kuroda; Toshihiro Akisue; Hideki Moriyama
Journal:  Calcif Tissue Int       Date:  2021-03-22       Impact factor: 4.333

6.  Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma.

Authors:  Gustavo Davi Rabelo; Claudia Coutinho-Camillo; Luiz Paulo Kowalski; Nathalie Portero-Muzy; Jean-Paul Roux; Pascale Chavassieux; Fabio Abreu Alves
Journal:  Clin Oral Investig       Date:  2017-06-24       Impact factor: 3.573

Review 7.  Pro-inflammatory Cytokines and Osteocytes.

Authors:  Miao Zhou; Shuyi Li; Janak L Pathak
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

8.  Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism.

Authors:  Orlando M Gutiérrez; Alexandra Luzuriaga-McPherson; Yiming Lin; Linda C Gilbert; Shin-Woo Ha; George R Beck
Journal:  J Clin Endocrinol Metab       Date:  2015-08-31       Impact factor: 5.958

9.  Associations of serum sclerostin with bone mineral density, markers of bone metabolism and thalassaemia characteristics in adult patients with transfusion-dependent beta-thalassaemia.

Authors:  Katya Sapunarova; Vesselina Goranova-Marinova; Pencho Georgiev; Tanya Deneva; Silvia Tsvetkova; Zhanet Grudeva-Popova
Journal:  Ann Med       Date:  2020-03-26       Impact factor: 4.709

Review 10.  The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.

Authors:  Peipei Duan; L F Bonewald
Journal:  Int J Biochem Cell Biol       Date:  2016-05-19       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.